Intrinsic Value of S&P & Nasdaq Contact Us

Adlai Nortye Ltd. ANL NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • KY • USD

SharesGrow Score
42/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$16.00
+17.5%

Adlai Nortye Ltd. (ANL) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.

The consensus price target is $16.00, representing an upside of 17.5% from the current price $13.62.

Analysts estimate Earnings Per Share (EPS) of $-0.88 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-4.89 vs est $-0.88 (missed -455.7%). Analyst accuracy: 18%.

ANL Stock — 12-Month Price Forecast

$16.00
▲ +17.47% Upside
Average Price Target
Based on 1 Wall Street analysts offering 12-month price targets for Adlai Nortye Ltd., the price target is $16.00.
The average price target represents a +17.47% change from the last price of $13.62.

ANL Analyst Ratings

Buy
1
Ratings
1 Buy
Based on 1 analysts giving stock ratings to Adlai Nortye Ltd. in the past 3 months
Rating breakdown
Buy
1 100%
100%
Buy
1 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — ANL

18%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024 Actual –$4.89 vs Est –$0.88 ▼ 82.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — ANL

Revenue Trend
Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message